Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 20001-20050 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06308419
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
PHASE1
Recruiting
12 participants
Started: Aug 14, 2024 · Completed: Feb 1, 2031
2 conditions
2 sponsors
1 location
NCT06726356
Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.
NA
Recruiting
180 participants
Started: Aug 14, 2024 · Completed: Jul 30, 2026
1 condition
5 sponsors
1 location
NCT06526260
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
NA
Recruiting
80 participants
Started: Aug 14, 2024 · Completed: Jan 1, 2026
1 condition
2 sponsors
1 location
NCT06602622
Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
PHASE4
Recruiting
108 participants
Started: Aug 14, 2024 · Completed: Nov 14, 2025
6 conditions
1 sponsor
2 locations
NCT05041140
Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
N/A
Recruiting
25 participants
Started: Aug 14, 2024 · Completed: Jul 20, 2027
3 conditions
1 sponsor
1 location
NCT06247995
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.
PHASE1/PHASE2
Recruiting
58 participants
Started: Aug 14, 2024 · Completed: Sep 9, 2031
1 condition
1 sponsor
32 locations
NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
PHASE2
Recruiting
15 participants
Started: Aug 14, 2024 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT06291922
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
NA
Recruiting
100 participants
Started: Aug 14, 2024 · Completed: Jun 30, 2028
1 condition
2 sponsors
4 locations
NCT06597474
Food-Body-Mind Intervention (16 Weeks)
PHASE2/PHASE3
Recruiting
800 participants
Started: Aug 14, 2024 · Completed: Jul 31, 2028
5 conditions
1 sponsor
1 location
NCT06529003
TENS Unit To Decrease Pain After Laminaria Insertion
NA
Recruiting
36 participants
Started: Aug 14, 2024 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT06981234
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
PHASE2
Recruiting
25 participants
Started: Aug 14, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06577987
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
PHASE1
Recruiting
220 participants
Started: Aug 14, 2024 · Completed: Mar 14, 2027
10 conditions
1 sponsor
10 locations
NCT06577623
In-Person Mindfulness-based Intervention for Adolescents with Autism Spectrum Disorder and Their Caregivers
NA
Recruiting
28 participants
Started: Aug 14, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06529575
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
N/A
Recruiting
650 participants
Started: Aug 14, 2024 · Completed: Dec 31, 2028
2 conditions
5 sponsors
3 locations
NCT06557148
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer
N/A
Recruiting
30 participants
Started: Aug 13, 2024 · Completed: Aug 13, 2027
6 conditions
1 sponsor
7 locations
NCT06438315
SuperSaturated Oxygen Comprehensive Observational Registry
N/A
Recruiting
1,000 participants
Started: Aug 13, 2024 · Completed: Mar 31, 2029
2 conditions
1 sponsor
21 locations
NCT06527599
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
NA
Recruiting
107 participants
Started: Aug 13, 2024 · Completed: Jun 30, 2026
2 conditions
3 sponsors
2 locations
NCT06401356
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
PHASE3
Recruiting
50 participants
Started: Aug 13, 2024 · Completed: Jun 30, 2027
3 conditions
1 sponsor
15 locations
NCT06500780
Equity Using Interventions for Pain and Depression
NA
Recruiting
304 participants
Started: Aug 13, 2024 · Completed: May 31, 2027
4 conditions
2 sponsors
1 location
NCT06783101
Using a Smart Inhaler to Support Asthma Management in Adolescents With Intellectual and Developmental Disabilities
NA
Recruiting
30 participants
Started: Aug 13, 2024 · Completed: Apr 30, 2025
4 conditions
1 sponsor
1 location
NCT06341179
Effect of Sleep Extension on Overweight and Learning in Children
NA
Recruiting
300 participants
Started: Aug 13, 2024 · Completed: Dec 31, 2028
4 conditions
6 sponsors
3 locations
NCT05766592
Affirmative Family and Individual Psychotherapy for Sexual and Gender Minority Adults and Their Nonaccepting Parents
PHASE3
Recruiting
124 participants
Started: Aug 13, 2024 · Completed: Jun 30, 2027
2 conditions
3 sponsors
2 locations
NCT06444477
Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer
N/A
Recruiting
70 participants
Started: Aug 13, 2024 · Completed: Feb 28, 2025
4 conditions
1 sponsor
20 locations
NCT06656624
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
PHASE2
Recruiting
190 participants
Started: Aug 13, 2024 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT06508658
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PHASE3
Recruiting
360 participants
Started: Aug 13, 2024 · Completed: Jan 31, 2028
1 condition
2 sponsors
164 locations
NCT06115499
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
PHASE2/PHASE3
Recruiting
100 participants
Started: Aug 13, 2024 · Completed: Dec 9, 2029
7 conditions
2 sponsors
342 locations
NCT06435429
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
PHASE3
Recruiting
550 participants
Started: Aug 13, 2024 · Completed: Nov 26, 2031
1 condition
1 sponsor
163 locations
NCT06470100
Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty
PHASE4
Recruiting
90 participants
Started: Aug 13, 2024 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT06353906
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
PHASE2
Recruiting
27 participants
Started: Aug 13, 2024 · Completed: Jan 14, 2028
6 conditions
2 sponsors
2 locations
NCT06931275
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
NA
Recruiting
1,178 participants
Started: Aug 13, 2024 · Completed: Jul 30, 2027
1 condition
1 sponsor
2 locations
NCT05856643
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma
EARLY_PHASE1
Recruiting
12 participants
Started: Aug 13, 2024 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT05847517
Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)
PHASE3
Recruiting
350 participants
Started: Aug 13, 2024 · Completed: Dec 31, 2027
1 condition
3 sponsors
10 locations
NCT06529250
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
NA
Recruiting
148 participants
Started: Aug 13, 2024 · Completed: Sep 1, 2028
1 condition
1 sponsor
1 location
NCT06505057
Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH)
NA
Recruiting
100 participants
Started: Aug 13, 2024 · Completed: Jul 31, 2041
1 condition
1 sponsor
1 location
NCT06681623
A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
N/A
Recruiting
20 participants
Started: Aug 13, 2024 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06531824
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
PHASE3
Recruiting
11,000 participants
Started: Aug 13, 2024 · Completed: Aug 30, 2028
1 condition
1 sponsor
222 locations
NCT06503692
Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
NA
Recruiting
140 participants
Started: Aug 13, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT06396533
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
N/A
Recruiting
92 participants
Started: Aug 13, 2024 · Completed: Feb 23, 2029
3 conditions
2 sponsors
1 location
NCT06553898
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
PHASE1
Recruiting
18 participants
Started: Aug 13, 2024 · Completed: Jul 31, 2027
2 conditions
1 sponsor
1 location
NCT06226025
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
PHASE2
Recruiting
50 participants
Started: Aug 13, 2024 · Completed: Apr 30, 2026
2 conditions
4 sponsors
1 location
NCT06861530
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
N/A
Recruiting
40 participants
Started: Aug 13, 2024 · Completed: Jun 30, 2026
3 conditions
2 sponsors
2 locations
NCT06740955
Hypofractionated Radiotherapy
NA
Recruiting
420 participants
Started: Aug 13, 2024 · Completed: Dec 30, 2028
1 condition
1 sponsor
1 location
NCT06840665
MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
PHASE2
Recruiting
46 participants
Started: Aug 13, 2024 · Completed: Feb 12, 2027
1 condition
1 sponsor
1 location
NCT06757738
A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers
PHASE1
Recruiting
32 participants
Started: Aug 13, 2024 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT06540521
Bolt CSP-M Holter Study
N/A
Recruiting
75 participants
Started: Aug 13, 2024 · Completed: Jun 30, 2026
2 conditions
1 sponsor
2 locations
NCT06492304
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies
PHASE1/PHASE2
Recruiting
290 participants
Started: Aug 13, 2024 · Completed: Nov 30, 2030
3 conditions
1 sponsor
7 locations
NCT06373458
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
PHASE2
Recruiting
30 participants
Started: Aug 13, 2024 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT06727162
The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
N/A
Recruiting
100 participants
Started: Aug 13, 2024 · Completed: Oct 10, 2025
1 condition
1 sponsor
1 location
NCT06532578
Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus
PHASE2
Recruiting
240 participants
Started: Aug 13, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06592170
Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL)
PHASE1/PHASE2
Recruiting
35 participants
Started: Aug 13, 2024 · Completed: Aug 13, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
398
399
400
401
402
403
404
More pages
1333
Next